Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-06-02
1997-09-02
Travers, Russell
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61K 31535
Patent
active
056631693
ABSTRACT:
Certain benzoxazinones are useful in the inhibition of HIV reverse transcriptase (including its resistant varieties), the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable saks, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
REFERENCES:
patent: 3526621 (1970-09-01), Bernardi et al.
patent: 3682933 (1972-08-01), Engel
patent: 4313873 (1982-02-01), Lim
patent: 4857511 (1989-08-01), Rideout et al.
patent: 5179093 (1993-01-01), Afonso et al.
patent: 5434152 (1995-07-01), Huffman et al.
Young et al 120 CA: 270428c 1994.
"AIDS, The unanswered questions", Science, vol. 260, pp. 1253-1293, (May, 1993).
Young, et al., "Diazines", Chem. Ab., vol. 120, 270423, p. 1074, (1994).
Mayers, D.,"A double blind pilot to evaluate the antiviral activity, tolerability & pharmacokinetics of DMP 266 alone & in combination with indinavir", Abstract No. LB8a, 36th Interscience Conference on Antimicrobial Agents & Chemotherapy, (1996).
Young, L. S., et al., "Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria", Amer. J. of Medicine, vol. 82(Suppl. 4a), pp. 23-26, (1987).
Bernardi, L., et al., "Central depressant properties of 3,1-benzoxazine derivatives", Experientia, vol. 25(8), pp. 787-788, (1969).
Carretero, J.C., et al., "A practical route to C-8 substituted fluoroquinolones", Tetrahedron, vol. 48(35), pp. 7373-7382, (1992).
Rastogi, N., et al., "Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis", Antimicrobial Agents & Chemotherapy, vol. 34(5), pp. 759-764, (1990).
Kukla, M.J., et al., "Synthesis and Anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) derivatives", J. of Medicinal Chem., vol. 34(11), pp. 3187-3197 (1981).
Gioia, B., et al., "Identification of the metabolites of brofoxine in rate urine. Mass spectrometry studies", Adv. Mass. Spectrum, 7B, pp. 1622-1627, (1978).
Banerjee, D.K., et al., "Evaluation of the activity of a number of antimicrobial agents against mycobacteria within mouse macrophages by a radiometric method", J. of Antimicrobial Chemotherapy, vol. 31, pp. 289-302 (1993).
Hartman, R.J., et al., "Effects of brofoxine, a new anxiolytic on experimentally induced conflict in rats", Proc. West. Pharmacol, Soc., vol. 21, pp. 51-55 (1978).
Nozaki-Renard, J., et al., "A fluoroquinolone (DR-3355) protects human lymphocyte cell lines from HIV-1-induced cytotoxicity", AIDS, (London), vol. 4(12), pp. 1283-1286, (1990).
Menozzi, M., et al., "Interaction of brofoxine with serum proteins", Farmaco, Ed. Sci., vol. 35(1), pp. 79-88 (1980).
Lewin, C.S., et al., "Susceptibility of bacterial isolates from AIDS patients to six fluoroquinolones", J. Pharm., & Pharmacol., vol. 42(11), pp. 808-809, (1990).
Lewin, C.S., et al., "Antibacterial activity of fluoroquinolones in combination with zidovudine", J. Med. Microbiol., vol. 33, pp. 127-131 (1990).
Nozaki-Renard, J., et al., "Fluoroquinolones protect the human lymphocyte CEM cell line from HIV-1-mediated cytotoxicity", Cell Structure & Function, vol. 15(5), pp. 295-299 (1990).
Nordmann, P., et al., "In-vitro antimicrobial susceptibility of Rhodococcus equi", J. of Antimicro. Chemotherapy, vol. 29, pp. 383-393 (1992).
Britcher Susan F.
Lumma, Jr. William C.
Payne Linda S.
Tran Lekhanh O.
Young Steven D.
Camara Valerie J.
Daniel Mark R.
Merck & Co. , Inc.
Travers Russell
LandOfFree
Benzoxazinones as inhibitors of HIV reverse transcriptase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzoxazinones as inhibitors of HIV reverse transcriptase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzoxazinones as inhibitors of HIV reverse transcriptase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-308398